Your browser doesn't support javascript.
Adult-Onset Still's Disease After the ChAdOx1 nCoV-19 Vaccine.
AlQudari, Elham A; Alabdan, Lulwah I; Alkhathami, Abdulla A; Alotaibi, Mohammed D; Alhamzi, Hanan A.
  • AlQudari EA; Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
  • Alabdan LI; Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
  • Alkhathami AA; Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
  • Alotaibi MD; Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
  • Alhamzi HA; Department of Medicine, Prince Mohammed bin Abdulaziz Hospital, Riyadh, SAU.
Cureus ; 14(1): e21279, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1677764
ABSTRACT
Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: Cureus Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: Cureus Year: 2022 Document Type: Article